Tranzyme to present data on Ghrelin agonist TZP-101 at ADA

Data to be presented at this weeks ADA meeting show Tranzyme’s Ghrelin Agonist TZP-101 to reduce gastric emptying in patients with diabetes and severe symptomatic gastroparesis.

EPIX trigger milestone in GPCR drug discovery collaboration with GSK

EPIX Pharmaceuticals has achieved a key milestone in its collaboration with GlaxoSmithKline. EPIX has delivered a third GPCR candidate into lead optimization